Antithrombotic Therapy for Secondary Stroke Prevention in Patients With Symptomatic Large-Artery Atherosclerosis and Atrial Fibrillation: A Multicenter Experience.
BACKGROUND Optimal antithrombotic therapy for ischemic stroke due to symptomatic large-artery atherosclerosis in patients with atrial fibrillation remains uncertain. We describe real-world prescribing patterns and outcomes across antithrombotic regimens. METHODS We retrospectively analyzed consecutive patients with a...